Identification and functional analysis of CBLB mutations in type 1 diabetes

Biochemical and Biophysical Research Communications
Norihide YokoiNorihide Yokoi

Abstract

Casitas B-lineage lymphoma b (Cblb) is a negative regulator of T-cell activation and dysfunction of Cblb in rats and mice results in autoimmunity. In particular, a nonsense mutation in Cblb has been identified in a rat model of autoimmune type 1 diabetes. To clarify the possible involvement of CBLB mutation in type 1 diabetes in humans, we performed mutation screening of CBLB and characterized functional properties of the mutations in Japanese subjects. Six missense mutations (A155V, F328L, N466D, K837R, T882A, and R968L) were identified in one diabetic subject each, excepting N466D. Of these mutations, F328L showed impaired suppression of T-cell activation and was a loss-of-function mutation. These data suggest that the F328L mutation is involved in the development of autoimmune diseases including type 1 diabetes, and also provide insight into the structure-function relationship of CBLB protein.

References

Apr 1, 1994·Tissue Antigens·D P Sengar, R Goldstein
Oct 23, 1997·The Journal of Clinical Investigation·N YokoiK Komeda
Jun 11, 1999·Oncogene·M M KeaneS Lipkowitz
Jul 16, 2002·Nature Genetics·Norihide YokoiSusumu Seino
Feb 13, 2004·Genes and Immunity·R KosoyP Concannon
Jan 5, 2005·Journal of Leukocyte Biology·Regine BergholdtFlemming Pociot
Oct 11, 2005·The Biochemical Journal·Christine B F Thien, Wallace Y Langdon
Oct 18, 2005·Current Opinion in Immunology·Lisa M Maier, Linda S Wicker
Jan 9, 2007·Journal of Leukocyte Biology·Felicity PayneJohn A Todd
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium

❮ Previous
Next ❯

Citations

Feb 4, 2012·Nature Structural & Molecular Biology·Stephen C KalesStanley Lipkowitz
Dec 14, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yoshihiro KobashigawaFuyuhiko Inagaki
Apr 16, 2010·Arthritis Research & Therapy·Angélica M Delgado-VegaSergey V Kozyrev
Feb 16, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Santosh Kumar GoruAnil Bhanudas Gaikwad
Oct 8, 2015·Kidney International·Sandhya S ThomasWilliam E Mitch
Oct 4, 2015·Biochemical Pharmacology·Aileen King, James Bowe
Apr 22, 2016·Diabetes, Obesity & Metabolism·X-D YangY-Y Yang
Mar 28, 2017·World Journal of Diabetes·Tomoki AbeTakeshi Nikawa
Aug 10, 2013·Molecular Endocrinology·Sabeera BonalaRavi Kambadur
Mar 13, 2014·Endocrine Journal·Tomoki AbeTakeshi Nikawa
Jan 21, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gerard F HoyneChristopher C Goodnow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.